We’re pleased to announce that Everything Genetic is celebrating its third anniversary.

Founded by our CEO, James Price in December 2016, Everything Genetic has enjoyed significant growth in its first three years. We now have a commercial team of six, supported by an expert panel of clinicians and post-test consultants.

We specialise in breast cancer and colorectal cancer genetic testing, as well as other gynaecological and urological cancers and heart conditions. By engaging with world-leading laboratories, we now boast a portfolio of market-leading genetic testing brands across the patient pathway from hereditary testing, diagnostics and prognostics, through to theragnostic genetic testing.

Commenting on the firm’s success and vision for the future, James said:

“I’m extremely proud of the significant progress we have made in the UK genetic testing market in such a short time.

“The market is buoyant and it is our aim to revolutionise the treatment of patients with cancer and heart conditions by making the best-in-class, most cost-effective genetic tests accessible to clinicians and patients alike for the detection, diagnosis and treatment of these life-threatening conditions.”

Everything Genetic provides a consultancy-based approach and distributor sales support for oncologists and surgeons in both public and private sector hospitals, as well as GP’s in private clinics and wellness centres, and direct patient sales for hereditary genetic tests.

We have built strong partnerships with leading private healthcare providers such as BMI Healthcare, HCA Healthcare and Nuffield Health, and private medical insurance companies for the reimbursement of genetic testing.

Photo from Left to Right above: Simon Davies (Commercial Director, Market Access), Sophie Harrison (Finance Manager), Sean McGrath (Non-Executive Director), Alexandra Heathcote (Office Manager), James Price (CEO/Founder), Calum Ewan (Medical Sales Representative), Mia Lesniewicz (Oncology Specialist – South UK)